These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35010512)

  • 1. Antimicrobial Usage and Resistance in Makkah Region Hospitals: A Regional Point Prevalence Survey of Public Hospitals.
    Haseeb A; Faidah HS; Algethamy M; Alghamdi S; Alhazmi GA; Alshomrani AO; Alqethami BR; Alotibi HS; Almutiri MZ; Almuqati KS; Albishi AA; Elrggal ME; Mahrous AJ; Khogeer AA; Saleem Z; Iqbal MS; Sheikh A
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point Prevalence Survey of Antimicrobial Use and Resistance during the COVID-19 Era among Hospitals in Saudi Arabia and the Implications.
    Haseeb A; Abuhussain SSA; Alghamdi S; Bahshwan SM; Mahrous AJ; Alzahrani YA; Alzahrani AF; AlQarni A; AlGethamy M; Naji AS; Khogeer AAO; Iqbal MS; Godman B; Saleem Z
    Antibiotics (Basel); 2023 Nov; 12(11):. PubMed ID: 37998811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A repeated point prevalence survey of antimicrobial use in specialized cancer care hospital of Pakistan: findings and implications.
    Saleem Z; Hassali MA; Hashmi FK; Godman B; Bhutta OA
    Hosp Pract (1995); 2019 Aug; 47(3):149-154. PubMed ID: 31180791
    [No Abstract]   [Full Text] [Related]  

  • 4. Global point prevalence survey of antimicrobial consumption in Brazilian hospitals.
    Porto APM; Goossens H; Versporten A; Costa SF;
    J Hosp Infect; 2020 Feb; 104(2):165-171. PubMed ID: 31678430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.
    Gharbi M; Doerholt K; Vergnano S; Bielicki JA; Paulus S; Menson E; Riordan A; Lyall H; Patel SV; Bernatoniene J; Versporten A; Heginbothom M; Goossens H; Sharland M;
    BMJ Open; 2016 Nov; 6(11):e012675. PubMed ID: 27810974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.
    Versporten A; Zarb P; Caniaux I; Gros MF; Drapier N; Miller M; Jarlier V; Nathwani D; Goossens H;
    Lancet Glob Health; 2018 Jun; 6(6):e619-e629. PubMed ID: 29681513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point prevalence survey of antibiotic use in 26 Saudi hospitals in 2016.
    Al Matar M; Enani M; Binsaleh G; Roushdy H; Alokaili D; Al Bannai A; Khidir Y; Al-Abdely H
    J Infect Public Health; 2019; 12(1):77-82. PubMed ID: 30270148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
    Korinteli IG; Mchedlishvili I; Javakhadze M; Versporten A; Goossens H; Phagava H; Pagava K
    Georgian Med News; 2019; (292-293):72-75. PubMed ID: 31560667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare-associated infections and antimicrobial use in acute care hospitals in Greece, 2022; results of the third point prevalence survey.
    Palaiopanos K; Krystallaki D; Mellou K; Kotoulas P; Kavakioti CA; Vorre S; Vertsioti G; Gkova M; Maragkos A; Tryfinopoulou K; Paraskevis D; Tsiodras S; Zaoutis T
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):11. PubMed ID: 38273402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications.
    Dlamini NN; Meyer JC; Kruger D; Kurdi A; Godman B; Schellack N
    Hosp Pract (1995); 2019 Apr; 47(2):88-95. PubMed ID: 30963821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antimicrobial use and healthcare-associated infections in China: Results from the first point prevalence survey in 18 hospitals in Shanxi Province.
    Li X; Cai W; Song Y; Kang J; Ji X; Tian F; Yin D; Wang S; Guo Q; Song J; Shi N; Duan J
    J Glob Antimicrob Resist; 2023 Jun; 33():283-290. PubMed ID: 37100239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey.
    Hufnagel M; Versporten A; Bielicki J; Drapier N; Sharland M; Goossens H;
    J Pediatric Infect Dis Soc; 2019 May; 8(2):143-151. PubMed ID: 29579259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals.
    Frenette C; Sperlea D; German GJ; Afra K; Boswell J; Chang S; Goossens H; Grant J; Lefebvre MA; McGeer A; Mertz D; Science M; Versporten A; Thirion DJG
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):104. PubMed ID: 32653046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point Prevalence Survey of Antimicrobial Use during the COVID-19 Pandemic among Different Hospitals in Pakistan: Findings and Implications.
    Saleem Z; Haseeb A; Godman B; Batool N; Altaf U; Ahsan U; Khan FU; Mustafa ZU; Nadeem MU; Farrukh MJ; Mugheera M; Rehman IU; Khan AF; Saeed H; Hossain MA; Raafat M; Radwan RM; Iqbal MS
    Antibiotics (Basel); 2022 Dec; 12(1):. PubMed ID: 36671271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan.
    Elhajji FD; Al-Taani GM; Anani L; Al-Masri S; Abdalaziz H; Qabba'h SH; Al Bawab AQ; Scott M; Farren D; Gilmore F; Versporten A; Goossens H; Aldeyab MA
    BMC Health Serv Res; 2018 Nov; 18(1):849. PubMed ID: 30419895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point prevalence survey of antimicrobial utilization in the cardiac and pediatric critical care unit.
    Blinova E; Lau E; Bitnun A; Cox P; Schwartz S; Atenafu E; Yau Y; Streitenberger L; Parshuram CS; Marshall J; Seto W
    Pediatr Crit Care Med; 2013 Jul; 14(6):e280-8. PubMed ID: 23823209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A national, multicentre, web-based point prevalence survey of antimicrobial use and quality indices among hospitalised paediatric patients across South Africa.
    Skosana PP; Schellack N; Godman B; Kurdi A; Bennie M; Kruger D; Meyer JC
    J Glob Antimicrob Resist; 2022 Jun; 29():542-550. PubMed ID: 34915203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point prevalence study of antimicrobial usage in acute care hospitals in the Slovak Republic.
    Štefkovičová M; Litvová S; Meluš V; Krištúfková Z; Bražinová A
    J Hosp Infect; 2016 Aug; 93(4):403-9. PubMed ID: 27156010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications.
    Skosana PP; Schellack N; Godman B; Kurdi A; Bennie M; Kruger D; Meyer JC
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1353-1366. PubMed ID: 33724147
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.
    Plachouras D; Kärki T; Hansen S; Hopkins S; Lyytikäinen O; Moro ML; Reilly J; Zarb P; Zingg W; Kinross P; Weist K; Monnet DL; Suetens C;
    Euro Surveill; 2018 Nov; 23(46):. PubMed ID: 30458917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.